960 related articles for article (PubMed ID: 28160338)
1. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
[TBL] [Abstract][Full Text] [Related]
2. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study.
Thomsen SF; Pritzier EC; Anderson CD; Vaugelade-Baust N; Dodge R; Dahlborn AK; Vestergaard C
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1048-1055. PubMed ID: 28294420
[TBL] [Abstract][Full Text] [Related]
3. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
[TBL] [Abstract][Full Text] [Related]
4. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
Maurer M; Giménez-Arnau A; Ensina LF; Chu CY; Jaumont X; Tassinari P
World Allergy Organ J; 2020 Sep; 13(9):100460. PubMed ID: 32983330
[TBL] [Abstract][Full Text] [Related]
5. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
[TBL] [Abstract][Full Text] [Related]
6. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
[TBL] [Abstract][Full Text] [Related]
8. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
Gimenez-Arnau A; Bartra J; Ferrer M; Jauregui I; Borbujo J; Figueras I; Muñoz-Bellido FJ; Pedraz J; Serra-Baldrich E; Tejedor-Alonso MA; Velasco M; Terradas P; Labrador M
J Investig Allergol Clin Immunol; 2022 Jun; 32(3):191-199. PubMed ID: 33349612
[TBL] [Abstract][Full Text] [Related]
9. Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study.
Savic S; Leeman L; El-Shanawany T; Ellis R; Gach JE; Marinho S; Wahie S; Sargur R; Bewley AP; Nakonechna A; Randall R; Fragkas N; Somenzi O; Marsland A
Clin Exp Dermatol; 2020 Dec; 45(8):1003-1010. PubMed ID: 32246853
[TBL] [Abstract][Full Text] [Related]
10. The burden of chronic urticaria: French baseline data from the international real-life AWARE study.
Guillet G; Bécherel PA; Pralong P; Delbarre M; Outtas O; Martin L; Pelvet B; Gharbi H; Giordano-Labadie F
Eur J Dermatol; 2019 Feb; 29(1):49-54. PubMed ID: 30827942
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
Fukunaga A; Oda Y; Washio K; Omori T; Kakei Y; Hide M; Nishigori C
Trials; 2020 Jan; 21(1):23. PubMed ID: 31906999
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data.
Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Maurer M; Weller K
Allergy; 2018 Mar; 73(3):576-584. PubMed ID: 29058822
[TBL] [Abstract][Full Text] [Related]
13. Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Staubach P; Metz M; Chapman-Rothe N; Sieder C; Bräutigam M; Canvin J; Maurer M
Allergy; 2016 Aug; 71(8):1135-44. PubMed ID: 27010957
[TBL] [Abstract][Full Text] [Related]
14. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
[TBL] [Abstract][Full Text] [Related]
15. Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study.
Maurer M; Houghton K; Costa C; Dabove F; Ensina LF; Giménez-Arnau A; Guillet G; Konstantinou GN; Labrador-Horrillo M; Lapeere H; Meshkova R; Pastorello EA; Velásquez-Lopera M; Tamayo Quijano LM; Vestergaard C; Chapman-Rothe N
World Allergy Organ J; 2018; 11(1):32. PubMed ID: 30464782
[TBL] [Abstract][Full Text] [Related]
16. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
[TBL] [Abstract][Full Text] [Related]
17. Chronic Urticaria in the Real-Life Clinical Practice Setting in Portugal: Baseline Results from the Non-Interventional Multicentre AWARE Study.
Costa C; Rosmaninho I; Guilherme A; Ferreira J; Antunes J; Pina A; Prates S; Marques JG; Azevedo F; Cunha AP; Brito C; Massa A; Sousa JT; Velho GC; Raposo I; Pinto GM; Sousa V; Martins AR
Acta Med Port; 2019 Feb; 32(2):133-140. PubMed ID: 30896394
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
[TBL] [Abstract][Full Text] [Related]
19. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
Lacour JP; Khemis A; Giordano-Labadie F; Martin L; Staumont-Salle D; Hacard F; Tian H; McBride D; Hollis K; Hunter S; Martin L; Lamirand A; Le Guen S; Balp MM; Berard F
Eur J Dermatol; 2018 Dec; 28(6):795-802. PubMed ID: 30698148
[TBL] [Abstract][Full Text] [Related]
20. Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study.
Giordano-Labadie F; Becherel PA; Pralong P; Outtas O; Ruer-Mulard M; Berard F; Greco M; Lacour JP; Debons-Peyroutet M; Pelvet B; Lamirand A; Guillet G
Eur J Dermatol; 2021 Apr; 31(2):217-224. PubMed ID: 34001470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
